跳至主要内容
临床试验/NCT03400657
NCT03400657Unknown不适用

A Prospective, Multicenter, Prospective, Non-intervention, Controlled Trial of MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer in Realistic Medical Practice

Peking University1 个研究点 分布在 1 个国家目标入组 484 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
484
试验地点
1
主要终点
overall survival

研究概览

简要总结

This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discussion under real medical practice.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Histopathological diagnosis of recurrent / metastatic gastric or colorectal cancer.
  • Participate in formal MDT discussions at the Research Center.
  • MDT decision-making at least two subjects involved in treatment.
  • Patient informed consent and signed written consent.

排除标准

  • Early or locally advanced gastric cancer or colorectal cancer.
  • Accept informal MDT discussions.
  • MDT decisions recommend only a single subject for treatment of patients.
  • MDT decisions recommend only palliative patients.

结局指标

主要结局

overall survival

时间窗: From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

次要结局

  • Differences in overall survival after performing MDT at center(1 years)

研究者

发起方
Peking University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shen Lin

Head of department of Gastroentestinal oncology

Peking University

研究点 (1)

Loading locations...

相似试验

MDT to Evaluate the Survival Benefit of Patients... | 临床试验